Human Adipose-Derived Stem Cells therapy (Gwo Xi Stem Cell Applied Technology)

N/A

Report date: 2026/03/11 20:02:12

Base Information

Drug NameHuman Adipose-Derived Stem Cells therapy (Gwo Xi Stem Cell Applied Technology)
Drug Alias NameAutologous ADSCs therapy (Gwo Xi Stem Cell Applied Technology)GXNPC1GXNPC-1
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGwo Xi Stem Cell Applied Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGwo Xi Stem Cell Applied Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A